Pharmacia Xalcom Would Be First Once-Daily Combo Glaucoma Therapy
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Pharmacia’s combination therapy Xalcom is poised to become the first once-daily, dual-action product for treatment for open-angle glaucoma. The company received an "approvable" letter for the fixed-combination product June 6 and is formulating its response to FDA.